Clinical Trials
159
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (119 trials with phase data)β’ Click on a phase to view related trials
Cannabis Use Registry to Improve Overall Understanding of Symptoms (CURIOUS)
- Conditions
- Cannabis UseCancer
- First Posted Date
- 2025-11-12
- Last Posted Date
- 2025-11-12
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 1000
- Registration Number
- NCT07227324
- Locations
- πΊπΈ
HealthPartners Institute Cancer Research Center, Saint Louis Park, Minnesota, United States
An Insole and Ankle Device for Monitoring Cognitive Decline in Individuals at Risk for Alzheimer's Disease and/or Alzheimer's Disease Related Dementias (AD/ADRD)
- Conditions
- Mild Cognitive Impairment (MCI)Dementia
- First Posted Date
- 2025-08-17
- Last Posted Date
- 2025-11-04
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 150
- Registration Number
- NCT07127133
- Locations
- πΊπΈ
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections
- Conditions
- Necrotizing Soft Tissue Infections
- First Posted Date
- 2025-08-13
- Last Posted Date
- 2025-09-17
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 30
- Registration Number
- NCT07120386
- Locations
- πΊπΈ
Regions Hospital, Saint Paul, Minnesota, United States
Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)
- Conditions
- CancerCancer (With or Without Metastasis)
- First Posted Date
- 2025-08-06
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 50
- Registration Number
- NCT07107607
- Locations
- πΊπΈ
HealthPartners Institute Cancer Research Center, Saint Louis Park, Minnesota, United States
TMS in Anxiety-Parkinson's Disease
- Conditions
- Parkinsons Disease (PD)Anxiety
- First Posted Date
- 2025-05-31
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- HealthPartners Institute
- Target Recruit Count
- 15
- Registration Number
- NCT06999330
- Locations
- πΊπΈ
HealthPartners Neuroscience Center, Saint Paul, Minnesota, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 32
- Next
News
Once-Weekly Insulin Icodec Combined with CGM Shows Promising Results for Type 2 Diabetes Management
Adults with type 2 diabetes achieved significant HbA1c reduction from 8.18% to 7% over 26 weeks using once-weekly insulin icodec combined with continuous glucose monitoring in the ONWARDS 9 trial.